Causes and Risk Factors for Scrotal Cancer

Key Takeaways

• Scrotal cancer is strongly linked to prolonged exposure to chemical carcinogens, particularly polycyclic aromatic hydrocarbons (PAHs) found in soot, tar, and mineral oils.
• Occupational exposure remains one of the most significant risk factors, especially in industries such as chimney sweeping, metalworking, and petroleum refining.
• Older age, immunosuppression, and a history of certain skin conditions or HPV infection can increase individual susceptibility.
• Squamous cell carcinoma is the most common histological type of scrotal cancer, though other forms such as basal cell carcinoma and extramammary Paget’s disease also occur.
• Preventive strategies—including protective clothing, skin surveillance, and workplace safety standards—can meaningfully reduce risk.

Causes and Risk Factors for Scrotal Cancer

Scrotal cancer arises when malignant cells develop in the scrotal skin or deeper tissue layers. Most cases originate in the squamous epithelium, making squamous cell carcinoma the predominant type. Less frequently, basal cell carcinoma, melanoma, and extramammary Paget’s disease can affect the scrotum. Although scrotal cancer accounts for a small fraction of male urogenital cancers overall, its association with specific carcinogens makes it a meaningful marker of environmental and occupational hazard.

The primary driver of scrotal cancer is prolonged contact with chemical carcinogens, most notably polycyclic aromatic hydrocarbons (PAHs). PAHs are produced during the incomplete combustion of organic matter and are found in coal tar, soot, mineral oils, and certain industrial byproducts. These compounds can penetrate scrotal skin due to its thin, rugated surface and relatively high permeability, allowing carcinogenic agents to damage DNA in epithelial cells over time. The latency period between initial exposure and tumor development can span decades, which complicates both diagnosis and attribution.

Human papillomavirus (HPV), particularly high-risk strains such as HPV-16, has also been identified as a contributing etiological factor in a subset of scrotal cancers. HPV-related oncogenic mechanisms—including the inactivation of tumor suppressor proteins p53 and pRb—can promote uncontrolled cellular proliferation in the scrotal epithelium. Chronic inflammatory conditions and pre-existing skin lesions, such as lichen sclerosus, may further predispose the scrotal skin to malignant transformation.

Occupational and Environmental Exposures Linked to Scrotal Cancer

Occupational risk factors for scrotal cancer have been recognized since 1775, when the British surgeon Percivall Pott described elevated rates of scrotal cancer among chimney sweeps exposed to coal soot. This landmark observation established one of the first causal links between occupational carcinogen exposure and cancer in medical history. Since then, researchers have identified a broad range of industries in which workers face heightened exposure to scrotal carcinogens, especially those involving mineral oils, cutting fluids, and coal tar derivatives.

Workers in the following occupations have historically demonstrated elevated rates of scrotal cancer due to routine exposure to PAHs, mineral oils, or related substances:

• Chimney sweeps and boiler workers (soot and combustion byproducts)
• Machinists and metalworkers (cutting oils and lubricants)
• Petroleum refinery workers (crude oil derivatives)
• Cotton mule spinners (mineral oils used in textile machinery)
• Shale oil workers (complex hydrocarbon mixtures)
• Road construction workers (coal tar and asphalt)

Environmental exposures outside traditional workplaces also warrant attention. Residential proximity to industrial facilities that emit PAHs, as well as the use of certain pesticides or petroleum-based products without adequate skin protection, has been associated with elevated cancer risk. Additionally, chronic ultraviolet (UV) radiation exposure may contribute to non-melanoma skin cancers of the scrotum, particularly in men who work outdoors for extended periods without protective clothing. While UV-related scrotal cancer is far less common than occupationally driven cases, it should not be dismissed in clinical assessments.

Importantly, improved workplace regulations and the introduction of health and safety standards throughout the twentieth century have reduced—but not eliminated—the burden of occupationally induced scrotal cancer. The U.S. Occupational Safety and Health Administration (OSHA) and equivalent regulatory bodies in other countries have established permissible exposure limits for many of the chemical agents linked to this malignancy. Despite these advances, legacy exposures from earlier decades continue to manifest as new diagnoses among older workers, reflecting the long latency period characteristic of chemically induced scrotal carcinoma.

Who Is Most at Risk for Developing Cancer of the Scrotum

Several demographic and clinical factors influence individual susceptibility to scrotal malignancy. Age is among the most consistent predictors: most cases are diagnosed in men over the age of 50, with peak incidence typically observed in the sixth and seventh decades of life. This pattern reflects both the cumulative nature of carcinogen exposure and the gradual decline in DNA repair efficiency that accompanies aging.

Men with prolonged occupational or environmental exposure to PAHs and mineral oils represent the highest-risk group, particularly those employed in the industries listed above before modern safety regulations were widely enforced. Immunocompromised individuals—including organ transplant recipients receiving long-term immunosuppressive therapy and people living with HIV—also face elevated risk, as reduced immune surveillance impairs the body’s ability to detect and destroy nascent malignant cells.

Summary of Key Risk Factors for Scrotal Cancer

Risk Factor	Mechanism or Association	Level of Evidence
PAH and mineral oil exposure	Direct DNA damage via carcinogenic hydrocarbons	Well established
HPV infection (high-risk strains)	Oncogenic inactivation of p53 and pRb	Moderate evidence
Advanced age (>50 years)	Cumulative exposure; reduced DNA repair	Well established
Immunosuppression	Impaired immune surveillance	Moderate evidence
Chronic skin conditions (e.g., lichen sclerosus)	Chronic inflammation promoting cellular transformation	Emerging evidence
UV radiation exposure	DNA photodamage in scrotal epithelium	Limited but recognized

Pre-existing dermatological conditions affecting the genital region may also raise risk. Lichen sclerosus, a chronic inflammatory skin disorder, has been associated with an increased likelihood of squamous cell carcinoma development at affected sites, including the scrotum. Men with a prior history of scrotal or penile cancer, or those with close relatives diagnosed with genitourinary malignancies, may benefit from more frequent dermatological surveillance.

Scrotal cancer causes and symptoms often overlap in presentation with benign conditions such as cysts, eczema, or fungal infections, which can delay diagnosis. Common early warning signs include persistent lumps, ulcerated lesions, thickened skin patches, or areas of discoloration on the scrotal surface that fail to resolve with standard treatment. Delayed recognition—combined with the rarity of the condition—means that many patients present at an advanced stage, underscoring the importance of awareness among both patients and clinicians.

Reducing Your Risk: Prevention Strategies for Scrotal Skin Cancer

Scrotal skin cancer causes and prevention are closely intertwined, since the majority of established risk factors are modifiable through behavioral change, workplace intervention, or medical management. The most impactful preventive measure for men in high-risk occupations is consistent use of barrier protection. Wearing impermeable protective clothing, changing out of contaminated garments promptly, and maintaining rigorous skin hygiene can substantially reduce carcinogen contact with scrotal tissue.

Employers in industries associated with PAH or mineral oil exposure are responsible for implementing engineering controls—such as enclosed cutting fluid systems and improved ventilation—alongside routine health surveillance programs. Workers in these environments should undergo periodic skin examinations as part of occupational health monitoring. Early identification of premalignant lesions, including erythroplasia of Queyrat or Bowen’s disease of the scrotum, allows for timely intervention before invasive cancer develops.

On an individual level, men can reduce their overall skin cancer risk through several practical approaches. Avoiding prolonged, unprotected sun exposure is advisable for men who work outdoors, as UV radiation contributes cumulatively to skin DNA damage. HPV vaccination, recommended by major health authorities including the Centers for Disease Control and Prevention (CDC) for eligible individuals, may offer protective benefit against HPV-related scrotal and genital cancers. Men with known risk factors or pre-existing genital skin conditions should discuss the frequency of clinical skin assessments with a dermatologist or urologist.

Cessation of tobacco use and maintaining a healthy immune system through balanced nutrition and disease management are additional steps that support overall cancer prevention. While no single intervention guarantees protection, combining workplace safety measures with personal vigilance and regular medical review offers the most comprehensive risk-reduction strategy available.

Frequently Asked Questions

Is scrotal cancer hereditary?

Scrotal cancer is not considered a primarily hereditary condition. Most cases are linked to environmental and occupational carcinogen exposure rather than inherited genetic mutations. However, a family history of genitourinary or skin cancers may suggest a shared genetic susceptibility to carcinogen-induced DNA damage, and men with such a history may benefit from earlier or more frequent dermatological screening as a precautionary measure.

How is scrotal cancer typically diagnosed?

Diagnosis usually begins with a physical examination of any suspicious scrotal lesion, followed by a biopsy to confirm malignancy and identify the tumor type. Imaging studies—such as ultrasound, CT scanning, or MRI—may be used to assess the extent of disease and determine whether lymph nodes or adjacent structures are involved. Early biopsy of persistent or unusual scrotal skin changes is critical, as prompt diagnosis significantly improves treatment outcomes.

Can scrotal cancer be prevented entirely?

Complete prevention cannot be guaranteed, but the risk can be meaningfully reduced. Eliminating or limiting exposure to known carcinogens such as PAHs and mineral oils is the most effective preventive strategy. Protective clothing, workplace safety protocols, HPV vaccination, routine skin surveillance, and prompt evaluation of any abnormal scrotal lesions collectively lower the probability of developing this cancer. Men in high-risk occupations should prioritize regular occupational health assessments.